Examination of protein binding partners may allow useful therapeutic targets to be identified.
First, Northern partners may provide access to enormous funding resources.
While an Asian OEM partner may provide the former, it seldom provides the latter.
Suppressive ART for the positive partner or topical or systemic pre-exposure prophylaxis (PrEP) for the negative partner may provide additional prevention options [ 46– 50].
Other binding partners may additionally contribute to the anti-apoptotic function of survivin-ΔEx3.
Thus, AKAP150 binding partners may somehow influence the enzymes that set insulin sensitivity.
Alteration in the expression of PSF and its binding partners may have potential as a therapeutic strategy against cancer [ 11].
Identification of Arabidopsis MTP5 binding partners may further elucidate the relationship between metal homeostasis and IAA-conjugate sensitivity.
During polarization, EB1 and its binding partners may mediate microtubule capture at the cortical actin patch (or Arp2/actin network).
Our recent theoretical study investigated the role that diffusible binding partners may play in regulating transport in a tissue [ 1].
